A detailed history of Manufacturers Life Insurance Company, The transactions in Repligen Corp stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 66,667 shares of RGEN stock, worth $10.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
66,667
Previous 67,701 1.53%
Holding current value
$10.3 Million
Previous $8.53 Million 16.25%
% of portfolio
0.01%
Previous 0.01%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$119.79 - $167.35 $123,862 - $173,039
-1,034 Reduced 1.53%
66,667 $9.92 Million
Q2 2024

Aug 14, 2024

BUY
$120.0 - $182.95 $353,520 - $538,970
2,946 Added 4.55%
67,701 $8.53 Million
Q1 2024

May 14, 2024

BUY
$170.78 - $208.42 $361,370 - $441,016
2,116 Added 3.38%
64,755 $11.9 Million
Q4 2023

Feb 13, 2024

SELL
$114.17 - $185.35 $134,378 - $218,156
-1,177 Reduced 1.84%
62,639 $11.3 Million
Q3 2023

Nov 15, 2023

BUY
$138.78 - $176.51 $1.04 Million - $1.32 Million
7,468 Added 13.25%
63,816 $10.1 Million
Q2 2023

Aug 11, 2023

BUY
$138.42 - $180.31 $109,490 - $142,625
791 Added 1.42%
56,348 $7.97 Million
Q1 2023

May 15, 2023

BUY
$154.26 - $198.1 $78,518 - $100,832
509 Added 0.92%
56,066 $9.44 Million
Q4 2022

Aug 11, 2023

BUY
$162.42 - $220.56 $112,881 - $153,289
695 Added 1.27%
55,557 $9.41 Million
Q4 2022

Feb 13, 2023

BUY
$162.42 - $220.56 $112,881 - $153,289
695 Added 1.27%
55,557 $9.41 Million
Q3 2022

Aug 11, 2023

BUY
$160.42 - $256.21 $53,259 - $85,061
332 Added 0.61%
54,862 $10.3 Million
Q3 2022

Nov 03, 2022

BUY
$160.42 - $256.21 $53,259 - $85,061
332 Added 0.61%
54,862 $10.3 Million
Q2 2022

Aug 11, 2023

BUY
$140.68 - $188.02 $100,445 - $134,246
714 Added 1.33%
54,530 $8.86 Million
Q2 2022

Aug 15, 2022

BUY
$140.68 - $188.02 $100,445 - $134,246
714 Added 1.33%
54,530 $8.89 Million
Q1 2022

Aug 11, 2023

SELL
$161.19 - $257.96 $362,677 - $580,410
-2,250 Reduced 4.01%
53,816 $10.1 Million
Q1 2022

May 20, 2022

SELL
$161.19 - $257.96 $11.4 Million - $18.2 Million
-70,707 Reduced 56.78%
53,816 $10.1 Million
Q4 2021

Feb 16, 2022

SELL
$247.59 - $304.47 $6.78 Million - $8.34 Million
-27,392 Reduced 18.03%
124,523 $33 Million
Q3 2021

Nov 12, 2021

BUY
$194.77 - $324.21 $1.33 Million - $2.22 Million
6,842 Added 4.72%
151,915 $43.9 Million
Q2 2021

Aug 12, 2021

BUY
$165.87 - $220.95 $3.57 Million - $4.75 Million
21,497 Added 17.4%
145,073 $29 Million
Q1 2021

May 03, 2021

BUY
$180.37 - $226.26 $8.73 Million - $10.9 Million
48,388 Added 64.36%
123,576 $24 Million
Q4 2020

Feb 12, 2021

SELL
$148.08 - $206.57 $489,256 - $682,507
-3,304 Reduced 4.21%
75,188 $14.4 Million
Q3 2020

Nov 09, 2020

BUY
$122.51 - $158.27 $105,481 - $136,270
861 Added 1.11%
78,492 $11.6 Million
Q2 2020

Aug 10, 2020

SELL
$94.33 - $140.48 $3.36 Million - $5 Million
-35,617 Reduced 31.45%
77,631 $9.25 Million
Q1 2020

May 15, 2020

BUY
$84.96 - $109.14 $303,986 - $390,502
3,578 Added 3.26%
113,248 $10.9 Million
Q4 2019

Feb 14, 2020

SELL
$73.84 - $93.08 $247,142 - $311,538
-3,347 Reduced 2.96%
109,670 $10.1 Million
Q3 2019

Nov 12, 2019

BUY
$76.65 - $95.51 $6.42 Million - $8 Million
83,794 Added 286.74%
113,017 $8.66 Million
Q2 2019

Aug 14, 2019

BUY
$54.2 - $85.95 $201,840 - $320,077
3,724 Added 14.6%
29,223 $2.51 Million
Q1 2019

May 13, 2019

BUY
$49.45 - $62.8 $71,850 - $91,248
1,453 Added 6.04%
25,499 $1.51 Million
Q4 2018

Feb 14, 2019

SELL
$48.26 - $68.88 $68,529 - $97,809
-1,420 Reduced 5.58%
24,046 $1.27 Million
Q3 2018

Nov 14, 2018

SELL
$46.8 - $58.97 $177,606 - $223,791
-3,795 Reduced 12.97%
25,466 $1.41 Million
Q2 2018

Aug 14, 2018

BUY
$35.26 - $47.04 $32,439 - $43,276
920 Added 3.25%
29,261 $1.38 Million
Q1 2018

May 15, 2018

SELL
$30.92 - $37.27 $21,674 - $26,126
-701 Reduced 2.41%
28,341 $1.03 Million
Q4 2017

Feb 08, 2018

BUY
$32.53 - $38.92 $21,762 - $26,037
669 Added 2.36%
29,042 $1.05 Million
Q3 2017

Nov 14, 2017

BUY
$36.98 - $46.06 $1.05 Million - $1.31 Million
28,373
28,373 $1.09 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.54B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.